Sensato Investors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-35,862
Closed -$1.49M 87
2018
Q4
$1.49M Buy
35,862
+20,557
+134% +$853K 0.39% 56
2018
Q3
$640K Buy
15,305
+9,297
+155% +$358K 0.11% 67
2018
Q2
$207K Sell
6,008
-6,113
-50% -$209K 0.03% 83
2018
Q1
$408K Sell
12,121
-260,654
-96% -$8.96M 0.06% 65
2017
Q4
$9.37M Buy
+272,775
New +$9.3M 1.18% 36

Other funds holding PFE

Sensato Investors's PFE Position: Q1 2019 in Review

Sensato Investors sold out of Pfizer (PFE) in Q1 2019, closing a stake of 35,862 shares — an estimated $1.49M sold.

Sensato Investors first reported a position in PFE in Q4 2017 and held it in 5 quarters. The position peaked at $9.37M in Q4 2017. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

  • Sensato Investors reported no remaining Pfizer position as of Q1 2019 after selling out during the quarter.
  • Sensato Investors sold 35,862 Pfizer shares in Q1 2019, an estimated $1.49M.
  • Sensato Investors first reported a position in Pfizer in Q4 2017 and held it in 5 quarters.
  • Sensato Investors's Pfizer position peaked at $9.37M in Q4 2017.
  • 2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on Sensato Investors's 13F filing for Q1 2019, filed 15 May 2019.